Leading Public

Digital Therapeutic Company

Dthera Sciences is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them.

About Us

Breaking News: DTHERA SCIENCES RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR ITS ALZHEIMER’S FOCUSED DEVELOPMENT-STAGE PRODUCT “DTHR-ALZ”

Dthera in the news- CBS Interview

Watch Dthera CEO Edward Cox talk about ReminX launch on CBS news.

ReminX Video

Dthera in the News

Dthera Sciences Launches ReminX – The First Digital Therapeutic Consumer Health Product for Individuals with Alzheimer’s Disease and Social Isolation

Stock Information

Click Here